✦ LIBER ✦

Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis

✍ Scribed by Przemyslaw J. Kotyla; Bogna Sliwinska-Kotyla; Eugene J. Kucharz

Publisher: Springer
Year: 2007
Tongue: English
Weight: 50 KB
Volume: 26
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-007-0657-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab treatment reduces the serum l

Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis

✍ Yasunori Kageyama; Hayato Kobayashi; Norihiko Kato 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 170 KB

The safety of infliximab, combined with

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial

✍ Rene Westhovens; David Yocum; John Han; Alberto Berman; Ingrid Strusberg; Piet G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

Association of the major histocompatibil

Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients

✍ Alfonso Martinez; Marina Salido; Gema Bonilla; Dora Pascual-Salcedo; Miguel Fern 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Objective: To determine whether major histocompatibility complex (mhc) polymorphisms are associated with a good or poor response to infliximab therapy in patients with rheumatoid arthritis (ra). ## Methods: Seventy-eight infliximab-treated patients with ra were genotyped for hla-drb1, hla-dqa1

Development of fatal tuberculosis in a p

Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: Comment on the article by Wolfe et al

✍ Esmeralda T. H. Molenaar; Irene E. M. Bultink; Ben A. C. Dijkmans; Willem F. Lem 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

An open-label pilot study of the effecti

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

✍ Arie E. van der Bijl; Ferdinand C. Breedveld; Christian E. Antoni; Joachim R. Ka 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 182 KB

The importance of the disease process an

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis

✍ Edwards, Christopher J. ;Cooper, Cyrus ;Fisher, David ;Field, Max ;van Staa, Tje 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views